Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on Terumo Health Outcomes (THO) and Medis Medical Imaging — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
Terumo Health Outcomes and Medis Medical Imaging Enter Strategic Partnership to Enhance Cardiovascular Care in the United States
Dec 10, 2024•over 1 year ago
Contract Type
partnership
BiotechnologyHealth CareMedical Device
Description
Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, have announced a strategic partnership in the United States. The partnership aims to enhance cardiovascular care through the utilization of Terumo's ePRISM™ precision medicine software platform and Medis' Quantitative Flow Ratio (QFR) technology.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months